|
|
|
| Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off. |
|
|
|
|
By Drug Delivery Leader: The Combination Products Handbook | In this Combination Products Handbook videocast, host Tom von Gunden discusses biologics delivery with chapter author Manfred Maeder and the book’s editor, Susan Neadle. Manfred and Susan discuss the challenges of transitioning large molecule formulations into combination products, taking into account product stability, usability, and the supply chain. | |
|
|
Preparing For The FDA QMSR: Will You Be Ready? | By Fran DeGrazio, executive editor, Drug Delivery Leader | The new FDA Quality Management System Regulation (QMSR) becomes effective in February 2026. In this article, DeGrazio discusses the implications for combination product and medical device developers as they prepare to demonstrate QMSR compliance. |
|
|
|
| Expanding Opportunities For Inhaled Drug Delivery | Article | By Gunilla Petersson, Ph.D., Nanoform | Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs. |
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
